<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Montelukast Monograph</title>
    <style>
        body {
            font-family: Arial, sans-serif;
            margin: 40px;
            background-color: #f9f9f9;
            color: #333;
        }
        h1, h2 {
            color: #005580;
        }
        table, th, td {
            border: 1px solid #ccc;
            border-collapse: collapse;
            padding: 10px;
        }
        table {
            width: 100%;
            margin-bottom: 20px;
        }
        a {
            color: #0066cc;
        }
        .logo {
            display: block;
            margin: 0 auto 20px auto;
            width: 150px;
        }
    </style>
</head>
<body>

    <!-- Clickable UMT Logo -->
    <a href="https://umt.edu.pk" target="_blank">
        <img src="https://umt.edu.pk/images/logo.png" alt="UMT Logo" class="logo">
    </a>

    <h1>Montelukast - Comprehensive Monograph</h1>
   
    <h2>Description:</h2>
    <p>Montelukast is a leukotriene receptor antagonist used in asthma therapy, exercise-induced breathing issues, and allergies.</p>

    <h2>Chemical Information:</h2>
    <ul>
        <li><strong>Formula:</strong> C35H36ClNO3S</li>
        <li><strong>Category:</strong> Leukotriene Receptor Antagonist (LRA)</li>
    </ul>

    <h2>Dosage Forms:</h2>
    <ul>
        <li>Tablets, chewable tablets, granules</li>
        <li>Strengths: 4mg, 5mg, 10mg</li>
    </ul>

    <h2>Indications:</h2>
    <ul>
        <li>Asthma: ≥12 months</li>
        <li>Exercise-Induced Bronchoconstriction: ≥6 years</li>
        <li>Allergic Rhinitis: Seasonal (≥2 years), Perennial (≥6 months)</li>
    </ul>

    <h2>Mechanism of Action:</h2>
    <p>Blocks leukotriene receptor CysLT1 to reduce inflammation, mucus, and bronchoconstriction.</p>

    <h2>Pharmacokinetics:</h2>
    <ul>
        <li>Absorption: 64% bioavailability</li>
        <li>Metabolism: CYP2C8, CYP3A4, CYP2C9</li>
        <li>Excretion: Bile/feces</li>
        <li>Half-life: 2.7–5.5 hours</li>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Montelukast Dosing Guide</title>
  <style>
    body { font-family: Arial; padding: 20px; background: #f8f9fa; color: #333; }
    h1, h2 { color: #0074b7; }
    table { width: 100%; border-collapse: collapse; margin: 20px 0; }
    th, td { border: 1px solid #ccc; padding: 10px; text-align: center; }
    th { background: #e3f2fd; }
  </style>
</head>
<body>
  <h1>Montelukast Dosing by Age and Indication</h1>

  <h2>1. Dosing by Age</h2>
  <table>
    <tr><th>Age Group</th><th>Minimum Dose</th><th>Maximum Dose</th><th>Dosage Form</th></tr>
    <tr><td>6–23 months</td><td>4 mg</td><td>4 mg</td><td>Oral granules (4 mg)</td></tr>
    <tr><td>2–5 years</td><td>4 mg</td><td>4 mg</td><td>Chewable tablet or granules</td></tr>
    <tr><td>6–14 years</td><td>5 mg</td><td>5 mg</td><td>Chewable tablet (5 mg)</td></tr>
    <tr><td>≥15 years</td><td>10 mg</td><td>10 mg</td><td>Film-coated tablet (10 mg)</td></tr>
  </table>

  <h2>2. Dosing by Indication</h2>
  <table>
    <tr><th>Disease</th><th>Age Group</th><th>Min Dose</th><th>Max Dose</th><th>Notes</th></tr>
    <tr><td>Asthma</td><td>≥6 months</td><td>4 mg</td><td>10 mg</td><td>Evening preferred</td></tr>
    <tr><td>Allergic Rhinitis</td><td>≥6 months</td><td>4 mg</td><td>10 mg</td><td>Any time of day</td></tr>
    <tr><td>Exercise-Induced Bronchoconstriction</td><td>≥6 years</td><td>5 mg (child)</td><td>10 mg (adult)</td><td>2 hours before exercise</td></tr>
    <tr><td>Asthma + Rhinitis</td><td>As per age</td><td>Same</td><td>Same</td><td>Do not exceed age-specific max</td></tr>
  </table>

  <p><strong>Note:</strong> Montelukast dosing is not weight-based. Follow age-specific max limits.</p>
</body>
</html>

    </ul>

    <h2>Adverse Effects:</h2>
    <ul>
        <li>Fatigue, behavior changes, cramps, rash, etc.</li>
    </ul>

    <h2>Contraindications:</h2>
    <ul>
        <li>Neuropsychiatric disorders, aspirin sensitivity, hepatic issues</li>
    </ul>

    <h2>Interactions:</h2>
    <ul>
        <li><strong>Food:</strong> No effect</li>
        <li><strong>Drugs:</strong> Acetaminophen, fluconazole</li>
        <li><strong>Disease:</strong> Liver, neuro, pulmonary</li>
    </ul>

    <h2>Pregnancy & Lactation:</h2>
    <ul>
        <li>Category B – Use only if clearly needed</li>
        <li>Breastfeeding: Caution advised</li>
    </ul>

    <h2>Off-Label Uses:</h2>
    <ul>
        <li>Chronic urticaria, eczema, AERD, cognitive disorders</li>
    </ul>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Montelukast Sodium vs. Potassium</title>
  <style>
    body { font-family: Arial; padding: 20px; background: #f8f9fa; color: #333; }
    h1, h2 { color: #0074b7; }
    table { width: 100%; border-collapse: collapse; margin: 20px 0; }
    th, td { border: 1px solid #ccc; padding: 10px; text-align: left; }
    th { background: #e3f2fd; }
  </style>
</head>
<body>
  <h1>Montelukast Sodium vs. Potassium</h1>

  <h2>1. Chemical Nature</h2>
  <table>
    <tr><th>Form</th><th>Description</th></tr>
    <tr><td>Montelukast Sodium</td><td>Most commonly used and approved salt form.</td></tr>
    <tr><td>Montelukast Potassium</td><td>Alternative form used in research/generics.</td></tr>
  </table>

  <h2>2. Clinical Use</h2>
  <table>
    <tr><th>Feature</th><th>Sodium</th><th>Potassium</th></tr>
    <tr><td>Formulations</td><td>Widely available</td><td>Rarely used clinically</td></tr>
    <tr><td>Bioequivalence</td><td>Reference standard</td><td>Must prove equivalence</td></tr>
    <tr><td>Regulatory Approval</td><td>FDA/EMA approved</td><td>Limited to generics</td></tr>
  </table>

  <h2>3. Pharmacological Activity</h2>
  <p>Both salt forms release the same active drug. Differences only affect formulation and stability.</p>

  <h2>4. Why Sodium Is Preferred</h2>
  <ul>
    <li>Better solid formulation stability</li>
    <li>Used in most clinical trials</li>
    <li>Available in major brands (e.g., Singulair®)</li>
  </ul>
</body>
</html>

    <h2>Common Brands in Pakistan:</h2>
    <table>
        <tr>
            <th>Brand</th>
            <th>Form</th>
            <th>Strength</th>
            <th>Manufacturer</th>
        </tr>
        <tr>
            <td>Myteka</td>
            <td>Tablet</td>
            <td>10 mg</td>
            <td>Hilton Pharma Ltd</td>
        </tr>
        <tr>
            <td>Montiget</td>
            <td>Tablet</td>
            <td>10 mg</td>
            <td>Getz Pharma</td>
        </tr>
        <tr>
            <td>Montika</td>
            <td>Tablet</td>
            <td>10 mg</td>
            <td>Sami Pharmaceuticals</td>
        </tr>
        <tr>
            <td>Ventomax</td>
            <td>Tablet</td>
            <td>10 mg</td>
            <td>Highnoon Labs</td>
        </tr>
    </table>

    <h2>Educational Video:</h2>
    <a href="https://youtu.be/1hFxnIgW1Kw?si=QEMw_brT_OsBkkm-" target="_blank">Watch on YouTube</a>

    <h2>References:</h2>
    <ul>
        <li><a href="https://www.drugs.com/pregnancy/montelukast.html">Drugs.com</a></li>
        <li><a href="https://go.drugbank.com/drugs/DB00471">DrugBank</a></li>
        <li><a href="https://en.wikipedia.org/wiki/Montelukast">Wikipedia</a></li>
        <li><a href="https://www.sciencedirect.com/topics/neuroscience/montelukast">ScienceDirect</a></li>
        <li>EMA. <em>Summary of Product Characteristics – Montelukast</em>. European Medicines Agency. Available at: <a href="https://www.ema.europa.eu/en/medicines/human/EPAR/singulair" target="_blank">https://www.ema.europa.eu/en/medicines/human/EPAR/singulair</a></li>
        <li>DailyMed. <em>Montelukast Sodium Label</em>. U.S. National Library of Medicine. Available at: <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=some-id" target="_blank">https://dailymed.nlm.nih.gov/</a></li>
        <li>PubChem. <em>Montelukast Sodium and Potassium Compound Summaries</em>. National Center for Biotechnology Information. Available at: <a href="https://pubchem.ncbi.nlm.nih.gov" target="_blank">https://pubchem.ncbi.nlm.nih.gov</a></li>
        <li>Martindale: The Complete Drug Reference</em>. Pharmaceutical Press. (Professional subscription required)</li>
    </ul>

</body>
</html>
